Patents by Inventor Catherine Tomaro-Duchesneau

Catherine Tomaro-Duchesneau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11028141
    Abstract: Embodiments of the disclosure encompass compositions and methods for the treatment of medical conditions in which increases in GLP-1 are beneficial to an individual. In specific embodiments, the disclosure concerns certain peptides that are capable of inducing GLP-1 production in an individual with a medical condition, such as type II diabetes or obesity. In other cases, an individual is not obese or overweight but is provided the peptide in an effort to reduce weight from fat.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: June 8, 2021
    Assignee: Baylor College of Medicine
    Inventors: Robert Allen Britton, Catherine Tomaro-Duchesneau
  • Publication number: 20190270790
    Abstract: Embodiments of the disclosure encompass compositions and methods for the treatment of medical conditions in which increases in GLP-1 are beneficial to an individual. In specific embodiments, the disclosure concerns certain peptides that are capable of inducing GLP-1 production in an individual with a medical condition, such as type II diabetes or obesity. In other cases, an individual is not obese or overweight but is provided the peptide in an effort to reduce weight from fat.
    Type: Application
    Filed: November 9, 2017
    Publication date: September 5, 2019
    Inventors: Robert Allen Britton, Catherine Tomaro-Duchesneau